Ezaki Glico, JP3161200005

Ezaki Glico partners with Viome: analysts target Ezaki Glico stock at JPY 3,900

Published on 10/06/2026 at 08:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached JPY 95.09 billion. Ezaki Glico stock costs EUR 28.30 on October 6, 2026 versus EUR 28.40, minus 0.35 percent.

Ezaki Glico, JP3161200005, Illustration mit AI erstellt.

Ezaki Glico (ISIN JP3161200005) is combining its food brands with personalized nutrition after partnering with Viome Life Sciences on a gut-health service for Japan. As Yahoo Finance reported on September 19, 2026, the deal involves Viome's mRNA HEALTH TRACKER, while the article cited a lower analyst target of JPY 3,900.

Viome adds a health angle

The partnership moves Ezaki Glico beyond conventional confectionery and dairy products toward data-linked nutrition services. The company already operates across confectionery, ice cream, milk and dairy, food ingredients, health products and overseas business, according to ENVALITH.

The strategic appeal is visible in the latest operating data. ENVALITH reported that overseas operating profit reached JPY 4.81 billion in the first quarter of fiscal 2026, up 46.70 percent year over year, although raw material costs continued to pressure domestic profitability.

Revenue rises while profit narrows

Ezaki Glico generated JPY 95.09 billion in revenue and JPY 1.39 billion in net income in the second quarter of fiscal 2026. Revenue was up 11.51 percent from JPY 85.28 billion in the first quarter, while quarterly net income fell from JPY 3.58 billion, according to Investing.com.

The figures leave investors with two competing signals: overseas expansion is improving the growth profile, but quarterly profitability remains uneven. The next earnings report is scheduled for November 6, 2026, giving the market a defined checkpoint for the health strategy and cost pressures.

Stock stays below its yearly high

Ezaki Glico was trading at EUR 28.30 at Lang & Schwarz on October 6, 2026 at 8:03 a.m. CEST, down 0.35 percent versus the Lang & Schwarz prior close of EUR 28.40 on October 5, 2026. The Tokyo-listed stock had a JPY 4,685 to JPY 6,290 52-week range and a market capitalization of JPY 308.4 billion as of October 6, 2026.